Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and report its third quarter 2025 ...

The support network that has emerged through the Mises Institute is really important. We feel like we’re all alone, but ...

The MTG x Avatar The Last Airbender expansion releases in November 2025, and with it some truly phenomenal cards.

If language is what makes us human, what does it mean now that large language models have gained “metalinguistic” abilities?

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

In her new music video, Selena Gomez dazzles in three diamond pieces from New Zealand luxury brand Layla Kaisi Collection’s ...

In a recent survey of law school admissions officers, 94% said the current political climate in the US played at least a ...

Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. *Data is provided by Barchart.com. Data reflects weightings calculated at ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...